David Restle

842 total citations
22 papers, 601 citations indexed

About

David Restle is a scholar working on Surgery, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Restle has authored 22 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Biomedical Engineering and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Restle's work include Cardiac Structural Anomalies and Repair (10 papers), Mechanical Circulatory Support Devices (10 papers) and Heart Failure Treatment and Management (7 papers). David Restle is often cited by papers focused on Cardiac Structural Anomalies and Repair (10 papers), Mechanical Circulatory Support Devices (10 papers) and Heart Failure Treatment and Management (7 papers). David Restle collaborates with scholars based in United States, China and Poland. David Restle's co-authors include Melissa G. Mendez, Paul A. Janmey, Michael A. Acker, Pavan Atluri, Carlo Bartoli, David M. Zhang, Jooeun Kang, C. Bermúdez, Faouzi Kallel and Jessica Howard and has published in prestigious journals such as Journal of the American College of Cardiology, Biomaterials and Annals of Surgery.

In The Last Decade

David Restle

21 papers receiving 596 citations

Peers

David Restle
Reginald Tran United States
Ali Nsair United States
Arkady Margulis United States
J Hutter United Kingdom
Ryan J. Nagao United States
Stephan Dobner Switzerland
Reginald Tran United States
David Restle
Citations per year, relative to David Restle David Restle (= 1×) peers Reginald Tran

Countries citing papers authored by David Restle

Since Specialization
Citations

This map shows the geographic impact of David Restle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Restle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Restle more than expected).

Fields of papers citing papers by David Restle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Restle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Restle. The network helps show where David Restle may publish in the future.

Co-authorship network of co-authors of David Restle

This figure shows the co-authorship network connecting the top 25 collaborators of David Restle. A scholar is included among the top collaborators of David Restle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Restle. David Restle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan, Shaohua Lu, David Restle, et al.. (2023). Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients With Stages II to III Lung Adenocarcinoma. Journal of Thoracic Oncology. 18(5). 608–619. 11 indexed citations
2.
Restle, David, Xiaoyu Li, Yan Li, et al.. (2023). Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma. Journal for ImmunoTherapy of Cancer. 11(6). e006609–e006609. 12 indexed citations
3.
Grosser, Rachel, Nabil P. Rizk, Laura H. Tang, et al.. (2023). A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal Adenocarcinoma. Annals of Surgery. 278(5). e1003–e1010. 1 indexed citations
4.
Chintala, Navin K., et al.. (2021). CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials. Lung Cancer. 157. 48–59. 23 indexed citations
5.
Restle, David, et al.. (2020). The role of surgeons during the COVID-19 pandemic: impact on training and lessons learned from a surgical resident’s perspective. Surgical Endoscopy. 35(7). 3430–3436. 9 indexed citations
6.
Bartoli, Carlo, David M. Zhang, Jooeun Kang, et al.. (2018). Clinical and In Vitro Evidence That Left Ventricular Assist Device–Induced von Willebrand Factor Degradation Alters Angiogenesis. Circulation Heart Failure. 11(9). e004638–e004638. 33 indexed citations
7.
Bartoli, Carlo, David Zhang, Jooeun Kang, et al.. (2017). LVAD-ASSOCIATED VON WILLEBRAND FACTOR DEGRADATION FRAGMENTS ALTER ANGIOGENESIS: A MECHANISTIC LINK BETWEEN LVAD SUPPORT, GASTROINTESTINAL ANGIODYSPLASIA, AND BLEEDING?. Journal of the American College of Cardiology. 69(11). 2552–2552. 1 indexed citations
8.
Bartoli, Carlo, David M. Zhang, Jooeun Kang, et al.. (2017). Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis. The Annals of Thoracic Surgery. 105(3). 807–814. 40 indexed citations
9.
Saxena, Vishal, Minwook Kim, Alexander L. Neuwirth, et al.. (2016). Anatomic Mesenchymal Stem Cell-Based Engineered Cartilage Constructs for Biologic Total Joint Replacement. Tissue Engineering Part A. 22(3-4). 386–395. 24 indexed citations
10.
Kang, Jooeun, David M. Zhang, David Restle, et al.. (2016). Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation. Journal of Thoracic and Cardiovascular Surgery. 151(6). 1747–1754.e1. 29 indexed citations
11.
Bartoli, Carlo, Jooeun Kang, David Restle, et al.. (2015). Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress. JACC Heart Failure. 3(11). 860–869. 52 indexed citations
12.
Kang, Jooeun, et al.. (2015). LVAD-Associated von Willebrand Factor Degradation Alters Angiogenesis: A Mechanistic Link Between LVAD Support, Gastrointestinal Angiodysplasia, and Bleeding?. The Journal of Heart and Lung Transplantation. 34(4). S13–S13. 1 indexed citations
13.
Kang, Jooeun, David Restle, Faouzi Kallel, et al.. (2015). Reduced Continuous-Flow LVAD Speed Does Not Decrease von Willebrand Factor Degradation. The Journal of Heart and Lung Transplantation. 34(4). S209–S209. 1 indexed citations
14.
Restle, David, David M. Zhang, George Hung, et al.. (2015). Preclinical Models for Translational Investigations of Left Ventricular Assist Device‐Associated von Willebrand Factor Degradation. Artificial Organs. 39(7). 569–575. 22 indexed citations
15.
Mendez, Melissa G., David Restle, & Paul A. Janmey. (2014). Vimentin Enhances Cell Elastic Behavior and Protects against Compressive Stress. Biophysical Journal. 107(2). 314–323. 146 indexed citations
16.
Bartoli, Carlo, David Restle, David M. Zhang, Michael A. Acker, & Pavan Atluri. (2014). Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: Mechanical demolition and enzymatic cleavage. Journal of Thoracic and Cardiovascular Surgery. 149(1). 281–289. 83 indexed citations
17.
Bartoli, Carlo, et al.. (2014). von Willebrand Factor Degradation with an LVAD Occurs via Two Distinct Mechanisms: Mechanical Demolition and Enzymatic Cleavage. The Journal of Heart and Lung Transplantation. 33(4). S23–S23. 1 indexed citations
18.
Chopra, Anant, Maria E. Murray, Fitzroy J. Byfield, et al.. (2013). Augmentation of integrin-mediated mechanotransduction by hyaluronic acid. Biomaterials. 35(1). 71–82. 99 indexed citations
19.
Restle, David. (2003). Silbenschnitt - Quantität - Kopplung: Zur Geschichte, Charakterisierung und Typologie der Anschlußprosodie. Bayerische Staatsbibliothek. 4 indexed citations
20.
Restle, David, et al.. (2002). Sounds and Systems. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026